← Evidence map

ArticleMolecular biomedicine2026

MET-mediated phosphorylation of YANK2 at Y282 inhibits NEDD4L-dependent SUMOylation and degradation, promoting chemoresistance in glioblastoma.

Yue Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

MET-mediated phosphorylation of YANK2 at Y282 inhibits NEDD4L-dependent SUMOylation and degradation, promoting chemoresistance in glioblastoma. | OpenQuestion